wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The aim of this study is to compare weekly-XELIRI(wXELIRI) regimen versus FOLFIRI regimen in the treatment of advanced colorectal cancer patients. The hypothesis is the efficacy of wXELIRI is not less than FOLFIRI with tolerable toxicity.
Epistemonikos ID: 50600de842e310bf42d82abaa2c3db7dc746b740
First added on: May 11, 2024